Indian Metals & Ferro Alloys Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: December 4, 2025, 1:07 am

Competitors of Indian Metals & Ferro Alloys Ltd

All Competitor Stocks of Indian Metals & Ferro Alloys Ltd

Quarterly Result

Last Updated: August 1, 2025, 7:30 pm

Below is a detailed analysis of the quarterly data for Indian Metals & Ferro Alloys Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 642.00 Cr.. The value appears strong and on an upward trend. It has increased from 567.00 Cr. (Mar 2025) to 642.00 Cr., marking an increase of 75.00 Cr..
• For Expenses, as of Jun 2025, the value is 516.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 497.00 Cr. (Mar 2025) to 516.00 Cr., marking an increase of 19.00 Cr..
• For Operating Profit, as of Jun 2025, the value is 125.00 Cr.. The value appears strong and on an upward trend. It has increased from 71.00 Cr. (Mar 2025) to 125.00 Cr., marking an increase of 54.00 Cr..
• For OPM %, as of Jun 2025, the value is 20.00%. The value appears strong and on an upward trend. It has increased from 12.00% (Mar 2025) to 20.00%, marking an increase of 8.00%.
• For Other Income, as of Jun 2025, the value is 22.00 Cr.. The value appears strong and on an upward trend. It has increased from 17.00 Cr. (Mar 2025) to 22.00 Cr., marking an increase of 5.00 Cr..
• For Interest, as of Jun 2025, the value is 7.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 10.00 Cr. (Mar 2025) to 7.00 Cr., marking a decrease of 3.00 Cr..
• For Depreciation, as of Jun 2025, the value is 15.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 14.00 Cr. (Mar 2025) to 15.00 Cr., marking an increase of 1.00 Cr..
• For Profit before tax, as of Jun 2025, the value is 126.00 Cr.. The value appears strong and on an upward trend. It has increased from 64.00 Cr. (Mar 2025) to 126.00 Cr., marking an increase of 62.00 Cr..
• For Tax %, as of Jun 2025, the value is 26.00%. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 26.00%.
• For Net Profit, as of Jun 2025, the value is 93.00 Cr.. The value appears strong and on an upward trend. It has increased from 47.00 Cr. (Mar 2025) to 93.00 Cr., marking an increase of 46.00 Cr..
• For EPS in Rs, as of Jun 2025, the value is 17.11. The value appears strong and on an upward trend. It has increased from 8.77 (Mar 2025) to 17.11, marking an increase of 8.34.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: October 15, 2025, 5:08 am

Growth

Last Updated: September 5, 2025, 7:20 am

Balance Sheet

Last Updated: December 4, 2025, 1:25 am

Below is a detailed analysis of the balance sheet data for Indian Metals & Ferro Alloys Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:

• For Equity Capital, as of Sep 2025, the value is 54.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 54.00 Cr..
• For Reserves, as of Sep 2025, the value is 2,456.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,294.00 Cr. (Mar 2025) to 2,456.00 Cr., marking an increase of 162.00 Cr..
• For Borrowings, as of Sep 2025, the value is 435.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 389.00 Cr. (Mar 2025) to 435.00 Cr., marking an increase of 46.00 Cr..
• For Other Liabilities, as of Sep 2025, the value is 450.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 441.00 Cr. (Mar 2025) to 450.00 Cr., marking an increase of 9.00 Cr..
• For Total Liabilities, as of Sep 2025, the value is 3,396.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 3,177.00 Cr. (Mar 2025) to 3,396.00 Cr., marking an increase of 219.00 Cr..
• For Fixed Assets, as of Sep 2025, the value is 1,051.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,050.00 Cr. (Mar 2025) to 1,051.00 Cr., marking an increase of 1.00 Cr..
• For CWIP, as of Sep 2025, the value is 197.00 Cr.. The value appears strong and on an upward trend. It has increased from 75.00 Cr. (Mar 2025) to 197.00 Cr., marking an increase of 122.00 Cr..
• For Investments, as of Sep 2025, the value is 1,008.00 Cr.. The value appears strong and on an upward trend. It has increased from 909.00 Cr. (Mar 2025) to 1,008.00 Cr., marking an increase of 99.00 Cr..
• For Other Assets, as of Sep 2025, the value is 1,141.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,144.00 Cr. (Mar 2025) to 1,141.00 Cr., marking a decrease of 3.00 Cr..
• For Total Assets, as of Sep 2025, the value is 3,396.00 Cr.. The value appears strong and on an upward trend. It has increased from 3,177.00 Cr. (Mar 2025) to 3,396.00 Cr., marking an increase of 219.00 Cr..

Notably, the Reserves (2,456.00 Cr.) exceed the Borrowings (435.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Mutual Fund Holdings

Key Financial Ratios

After reviewing the key financial ratios for Indian Metals & Ferro Alloys Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 70.19. This value is within the healthy range. It has decreased from 73.12 (Mar 24) to 70.19, marking a decrease of 2.93.
• For Diluted EPS (Rs.), as of Mar 25, the value is 70.19. This value is within the healthy range. It has decreased from 73.12 (Mar 24) to 70.19, marking a decrease of 2.93.
• For Cash EPS (Rs.), as of Mar 25, the value is 80.42. This value is within the healthy range. It has decreased from 83.47 (Mar 24) to 80.42, marking a decrease of 3.05.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 435.18. It has increased from 394.35 (Mar 24) to 435.18, marking an increase of 40.83.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 435.18. It has increased from 394.35 (Mar 24) to 435.18, marking an increase of 40.83.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 475.27. It has decreased from 515.23 (Mar 24) to 475.27, marking a decrease of 39.96.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 110.63. This value is within the healthy range. It has decreased from 116.58 (Mar 24) to 110.63, marking a decrease of 5.95.
• For PBIT / Share (Rs.), as of Mar 25, the value is 100.52. This value is within the healthy range. It has decreased from 102.12 (Mar 24) to 100.52, marking a decrease of 1.60.
• For PBT / Share (Rs.), as of Mar 25, the value is 95.28. This value is within the healthy range. It has decreased from 95.65 (Mar 24) to 95.28, marking a decrease of 0.37.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 70.30. This value is within the healthy range. It has increased from 69.01 (Mar 24) to 70.30, marking an increase of 1.29.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 70.19. This value is within the healthy range. It has decreased from 73.11 (Mar 24) to 70.19, marking a decrease of 2.92.
• For PBDIT Margin (%), as of Mar 25, the value is 23.27. This value is within the healthy range. It has increased from 22.62 (Mar 24) to 23.27, marking an increase of 0.65.
• For PBIT Margin (%), as of Mar 25, the value is 21.14. This value exceeds the healthy maximum of 20. It has increased from 19.82 (Mar 24) to 21.14, marking an increase of 1.32.
• For PBT Margin (%), as of Mar 25, the value is 20.04. This value is within the healthy range. It has increased from 18.56 (Mar 24) to 20.04, marking an increase of 1.48.
• For Net Profit Margin (%), as of Mar 25, the value is 14.79. This value exceeds the healthy maximum of 10. It has increased from 13.39 (Mar 24) to 14.79, marking an increase of 1.40.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 14.76. This value is within the healthy range. It has increased from 14.19 (Mar 24) to 14.76, marking an increase of 0.57.
• For Return on Networth / Equity (%), as of Mar 25, the value is 16.12. This value is within the healthy range. It has decreased from 18.60 (Mar 24) to 16.12, marking a decrease of 2.48.
• For Return on Capital Employeed (%), as of Mar 25, the value is 22.05. This value is within the healthy range. It has decreased from 25.24 (Mar 24) to 22.05, marking a decrease of 3.19.
• For Return On Assets (%), as of Mar 25, the value is 11.91. This value is within the healthy range. It has decreased from 13.93 (Mar 24) to 11.91, marking a decrease of 2.02.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 0.2. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.15. This value is within the healthy range. It has increased from 0.07 (Mar 24) to 0.15, marking an increase of 0.08.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 0.85. It has decreased from 1.01 (Mar 24) to 0.85, marking a decrease of 0.16.
• For Current Ratio (X), as of Mar 25, the value is 2.69. This value is within the healthy range. It has increased from 2.56 (Mar 24) to 2.69, marking an increase of 0.13.
• For Quick Ratio (X), as of Mar 25, the value is 1.67. This value is within the healthy range. It has increased from 1.46 (Mar 24) to 1.67, marking an increase of 0.21.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 3.50. This value is below the healthy minimum of 4. It has increased from 2.13 (Mar 24) to 3.50, marking an increase of 1.37.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 32.05. This value is within the healthy range. It has decreased from 37.60 (Mar 24) to 32.05, marking a decrease of 5.55.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 28.01. This value is within the healthy range. It has decreased from 31.39 (Mar 24) to 28.01, marking a decrease of 3.38.
• For Earning Retention Ratio (%), as of Mar 25, the value is 67.95. This value is within the healthy range. It has increased from 62.40 (Mar 24) to 67.95, marking an increase of 5.55.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 71.99. This value exceeds the healthy maximum of 70. It has increased from 68.61 (Mar 24) to 71.99, marking an increase of 3.38.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 21.12. This value is within the healthy range. It has increased from 18.00 (Mar 24) to 21.12, marking an increase of 3.12.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 14.42. This value is within the healthy range. It has increased from 11.66 (Mar 24) to 14.42, marking an increase of 2.76.
• For Enterprise Value (Cr.), as of Mar 25, the value is 3,653.32. It has increased from 3,532.68 (Mar 24) to 3,653.32, marking an increase of 120.64.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 1.42. This value is within the healthy range. It has increased from 1.27 (Mar 24) to 1.42, marking an increase of 0.15.
• For EV / EBITDA (X), as of Mar 25, the value is 6.12. This value is within the healthy range. It has increased from 5.62 (Mar 24) to 6.12, marking an increase of 0.50.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 1.28. This value is within the healthy range. It has increased from 1.24 (Mar 24) to 1.28, marking an increase of 0.04.
• For Retention Ratios (%), as of Mar 25, the value is 67.94. This value is within the healthy range. It has increased from 62.39 (Mar 24) to 67.94, marking an increase of 5.55.
• For Price / BV (X), as of Mar 25, the value is 1.40. This value is within the healthy range. It has decreased from 1.63 (Mar 24) to 1.40, marking a decrease of 0.23.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 1.28. This value is within the healthy range. It has increased from 1.24 (Mar 24) to 1.28, marking an increase of 0.04.
• For EarningsYield, as of Mar 25, the value is 0.11. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 24) which recorded 0.11.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness